ERVW-1 and infection: MARCHF8 targets several viral envelope glycoproteins to inhibit infections of HIV, vesicular stomatitis virus, rabies virus, lymphocytic choriomeningitis virus, severe acute respiratory syndrome coronavirus (SARS-CoV), chikungunya virus, and Ross River virus (70, –, 72).